World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
31234
World Ranking
13072
National Ranking
6674

Alexa B. Kimball publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alexa B. Kimball sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 451 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alexa B. Kimball D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alexa B. Kimball sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alexa B. Kimball is affiliated with Beth Israel Deaconess Medical Center in the United States with a research focus in medicine, particularly dermatology. Their work spans several subfields including surgery, epidemiology, immunology, and public health, environmental and occupational health. The primary emphasis of their research lies in the study of skin-related diseases and treatments.

The scientist's research covers a range of main topics, prominently featuring hidradenitis suppurativa and its treatments. Other key topics include colorectal and anal carcinomas, chemotherapy-related skin toxicity, microscopic colitis, dermatology and skin diseases in general, psoriasis focusing on treatment and pathogenesis, and anorectal disease treatments and outcomes.

Some of Alexa B. Kimball's recent papers include:

  • Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials, 2023, The Lancet
  • Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations, 2021, Journal of the American Academy of Dermatology
  • Impact of Endometriosis on Life-Course Potential: A Narrative Review, 2021, International Journal of General Medicine
  • Hidradenitis suppurativa, 2020, Nature Reviews Disease Primers
  • What causes hidradenitis suppurativa?-15 years after, 2020, Experimental Dermatology

Alexa B. Kimball has collaborated frequently with several researchers, including Martina L. Porter, Afsáneh Alavi, Errol P. Prens, Falk G. Bechara, and Shoba Ravichandran. These partnerships have contributed to a substantial body of work in the dermatological sciences.

The most common venues for publishing their research include:

  • Journal of the American Academy of Dermatology
  • Journal of Investigative Dermatology
  • Journal of the European Academy of Dermatology and Venereology
  • British Journal of Dermatology
  • International Journal of Women's Dermatology

Best Publications

  • Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

    Craig L Leonardi;Alexa B Kimball;Kim A Papp;Newman Yeilding

  • Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

    Alan Menter;Stephen K. Tyring;Kenneth Gordon;Alexa B. Kimball

  • IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

    Jason R. Chan;Wendy Blumenschein;Erin Murphy;Caroline Diveu

  • Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    Mark Lebwohl;Bruce Strober;Alan Menter;Kenneth Gordon

  • Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

    Andrew Blauvelt;Kim A. Papp;Christopher E.M. Griffiths;Bruce Randazzo;Bruce Randazzo

  • Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

    Alexa B Kimball;Martin M Okun;David A Williams;Alice B Gottlieb

  • The psychosocial burden of psoriasis.

    Alexa B Kimball;Christine Jacobson;Stefan Weiss;Mary G Vreeland

  • Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

    Kristian Reich;Kim A Papp;Andrew Blauvelt;Stephen K Tyring

  • National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

    Alexa B. Kimball;Dafna Gladman;Joel M. Gelfand;Kenneth Gordon

  • Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Parallel Randomized Trial

    Alexa B. Kimball;Francisco Kerdel;David Adams;Ulrich Mrowietz

  • Quantifying the harmful effect of psoriasis on health-related quality of life.

    Stefan C. Weiss;Alexa B. Kimball;David J. Liewehr;Andrew Blauvelt

  • Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events: A Meta-analysis of Randomized Controlled Trials

    Caitriona Ryan;Craig L. Leonardi;James G. Krueger;Alexa B. Kimball

  • Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies

    P.L. Mattei;K.C. Corey;A.B. Kimball

  • North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

    Ali Alikhan;Christopher Sayed;Afsaneh Alavi;Raed Alhusayen

  • The US dermatology workforce: A specialty remains in shortage

    Alexa Boer Kimball;Jack S. Resneck

  • North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management

    Ali Alikhan;Christopher Sayed;Afsaneh Alavi;Raed Alhusayen

  • Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis : Results of a Randomized, Placebo-Controlled, Phase 2 Trial

    Alexa B. Kimball;Kenneth B. Gordon;Richard G. Langley;Alan Menter

  • The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress.

    Annie Chiu;Susan Y. Chon;Alexa B. Kimball

  • Psoriasis: is the impairment to a patient's life cumulative?

    AB Kimball;U Gieler;D Linder;F Sampogna

  • Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

    Alexa B. Kimball;Francisco Kerdel;David Adams;Ulrich Mrowietz

Frequent Co-Authors

Kenneth B. Gordon
Kenneth B. Gordon Medical College of Wisconsin
Kim Papp
Kim Papp Probity Medical Research
Andrew Blauvelt
Andrew Blauvelt Veterans Health Administration
Richard G. Langley
Richard G. Langley Dalhousie University
Gregor B. E. Jemec
Gregor B. E. Jemec University of Copenhagen
Joel M. Gelfand
Joel M. Gelfand University of Pennsylvania
Kristian Reich
Kristian Reich University of Göttingen
Alan Menter
Alan Menter Texas A&M University
Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Craig L. Leonardi
Craig L. Leonardi Saint Louis University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in Medicine but seeking flexible options, there are several online degrees that can broaden your healthcare career pathway. Many students explore the cheapest mha programs online healthcare for an affordable route to leadership roles in hospital administration or healthcare organizations.

Nursing professionals who want to advance their clinical expertise might choose one of the best online bsn to dnp programs. These Doctor of Nursing Practice programs often offer flexible formats for registered nurses moving into higher-level practice or administrative positions.

For those interested in pharmacy, the 3 year online pharmd options provide a faster, more convenient pathway to becoming a pharmacist, especially for working professionals balancing education and career.

Lastly, the demand for health data specialists is growing. Students can enroll in online schools for health information management to prepare for roles in healthcare IT and patient data management.

Each of these accredited online programs can open doors to specialized healthcare roles—helping you build a rewarding healthcare career, even if you decide not to pursue a traditional MD degree.

Best Scientists Citing Alexa B. Kimball

Trending Scientists

Recently Published Articles